Keenova’s Blueprint to Bring
Clinical Data In-House

Keenova partnered with Atorus to bring its clinical data in-house. The biopharma replaced manual trackers with a single source of truth for trial status to accelerate delivery and establish data oversight.

Accelerating execution through SOP collaboration

Keenova and Atorus accelerated startup timelines by conducting a side-by-side SOP review. Leading with Atorus’ frameworks enabled faster study builds, allowing Keenova to refine its own internal standards as the project progressed.

Simplifying validation for faster study launches

Keenova and Atorus bypassed full-scale system implementation by using Veeva’s standard applications, allowing the teams to focus on study-specific validation. The clear distinction between IT-led system changes and protocol-specific builds ensures stakeholders stay in their defined lanes, reduces administrative burden, and accelerates the path to study launch.

Optimizing data review and oversight

Using existing standards for study builds and automating critical-to-quality (CtQ) checks through Veeva CDB, Keenova and Atorus drive efficiency by building a library of reusable assets for future trials. Real-time dashboards replace manual trackers, providing instant oversight and a single source of truth for study status.

Cultivating partnership

Keenova, Atorus, and Veeva leveraged each others’ expertise, frequently communicated, and shifted away from traditional hierarchies, to drive success with a shared strategy.

Learn how to ask your CRO for clinical technology.